Jordina Munrós-Feliu

Jordina Munrós-Feliu

Auto-generated profile, based on publicly available information

Jordina Munrós-Feliu

Atencio a la Salut Sexual i Reproductiva (ASSIR) Muntanya, Institut Català de la Salut Barcelona Spain

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2022 in Women's Health
Verified
Journal Article
Open access
LMLaura Medina-Perucha
Laura Medina-Perucha
APAndrea Pistillo
Andrea Pistillo
BRBerta Raventós
Berta Raventós
CJConstanza Jacques-Aviñó
Constanza Jacques-Aviñó
JMJordina Munrós-Feliu
Jordina Munrós-Feliu
TDTalita Duarte-Salles
Talita Duarte-Salles
Objective: Endometriosis greatly impacts women’s health and quality of life. However, research on the prevalence and incidence of endometriosis remains inconclusive. This study assesses time trends in the prevalence and incidence of endometriosis diagnoses in Catalonia (Spain) from 2009 to 2018, considering differences by age and socioeconomic status. Methods: Population-based cohort study using data from the Information System for Research in Primary Care (SIDIAP) database. Data were included from over 2.4 million women aged 15–55 years between 1 January 2006 and 31 December 2018. Results: A total of 2,337,717 women were selected as the incident population; 0.7% had an endometriosis diagnosis. Median (interquartile range) age at diagnosis was 37 (32–43) years. Most women were European (92.3%) and lived in urban areas (73.6%). Overall prevalence of endometriosis consistently increased during the 2009–2018 period, and it was 1.24% in 2018. Trends were the highest for women with less socioeconomic deprivation and for the 35–44 years age group. Median incidence rates were 94.9 (92.6–102.9) per 100,000 women-years, being the highest in women aged 35–44 years throughout the whole study period. Overall, incidence increased between 2015 and 2017, and plateaued or decreased in 2018. Incidence rates in women from the most deprived and rural areas were lower, although incidence time trends by socioeconomic status were unclear. Conclusion: Healthcare services and public health strategies need to be strengthened to ensure timely endometriosis diagnosis and treatment. Special attention should be given to the most affected populations and the social inequities of health.

1 January 2023 in Women's Health
Verified
Journal Article
Open access
AHAnna Sofie Holst
Anna Sofie Holst
CJConstanza Jacques-Aviñó
Constanza Jacques-Aviñó
ABAnna Berenguera
Anna Berenguera
CMCristina Martínez-Bueno
Cristina Martínez-Bueno
JMJordina Munrós-Feliu
Jordina Munrós-Feliu
LMLaura Medina-Perucha
Laura Medina-Perucha
Background: Available evidence suggests that menstrual health and management have been impaired during the COVID-19 syndemic. However, research in this area is scarce, and it is failing to voice the experiences of women and people who menstruate regarding their menstrual experiences. Objectives: This study aimed to explore the experiences of menstrual health and menstrual management among women and people who menstruate in the Barcelona area (Spain) during the COVID-19 syndemic. Design: This is a qualitative study, conducted taking a critical feminist approach, is embedded in the ‘Equity and Menstrual Health in Spain’ project. Methods: It includes photo-elicitation individual interviews with 34 women and people who menstruate in the area of Barcelona (Spain). Data were collected in person and through telephone calls between December 2020 and February 2021. Analyses were performed using Thematic Analysis. Results: Main findings navigated through the menstrual changes experienced by some participants, especially women living with long COVID-19, and the barriers to access healthcare and menstrual products during COVID-19. While some participants experienced menstrual poverty, this did not appear to be exacerbated during COVID-19. Instead, access to menstrual products was compromised based on products’ availability and mobility restrictions. Menstrual management and self-care were generally easier, given that menstrual experiences were almost exclusively relegated to private spaces during lockdown periods. Conclusions: Our findings highlight the need to further research and policy efforts towards promoting menstrual health and equity, considering social determinants of health, and taking intersectional and gender-based approaches. These strategies should be further encouraged in social and health crises such as the COVID-19 syndemic.

9 January 2026 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Open access
MSMaría Ángeles Sánchez-Durán
María Ángeles Sánchez-Durán
JEJuliana Esperalba
Juliana Esperalba
ESElena Scazzocchio
Elena Scazzocchio
IFIrene Fernández‐Torm
Irene Fernández‐Torm
EVEva Vázquez‐Segura
Eva Vázquez‐Segura
RGRoser Gol
Roser Gol
Objective: To determine the CMV seroprevalence among pregnant women and assess the rate of primary CMV infections during the first trimester. Design: Prospective multicentre observational cohort study. Setting: Four primary care centres (ASSIRs) and two tertiary hospitals in Barcelona and its metropolitan area. Pupulation or Sample: Pregnant women attending first‐trimester antenatal visits between October 2022 and September 2024. Methods: All participants underwent CMV IgG and IgM serological testing at the first antenatal visit. Women with positive IgM and low or intermediate IgG avidity were diagnosed with primary CMV infection and managed according to local protocols, including treatment with valaciclovir and fetal follow‐up. Main Outcome Measures: CMV screening acceptance rate, seroprevalence, rate of primary infection, fetal infection, and neonatal outcomes up to one year of age. Results: Of 3 677 pregnant women recruited, 3 357 were included in the final analysis. CMV screening acceptance was high. Seroprevalence was 77.7% (95% CI 76.2%–79.1%), and 743 women (22.1%, 95% CI 20.7%–23.6%) were seronegative. Five cases (0.15%, 95% CI 0.05%–0.37%) of primary CMV infection were identified and treated. No fetal infections were detected by amniocentesis. One newborn tested positive for CMV but remained asymptomatic at birth and at 6 months. Women who were seronegative were generally older, of European origin, and had higher education and employment rates. Conclusions: Universal first‐trimester CMV screening is feasible and well accepted in a public healthcare setting. While the rate of primary infection was low, early identification of seronegative women offers opportunities for preventive counselling and targeted follow‐up.